<DOC>
	<DOCNO>NCT01279876</DOCNO>
	<brief_summary>The purpose study determine whether melatonin effective treatment relapsing-remitting multiple sclerosis patient supplement main disease-modifying drug .</brief_summary>
	<brief_title>Melatonin Relapsing-Remitting Multiple Sclerosis Patients</brief_title>
	<detailed_description>Multiple sclerosis autoimmune chronic demyelinate disorder central nervous system , major cause disability youngster world , still definitely know etiology treatment . Melatonin hormone secrete pineal gland famous role circadian rhythm regulation , know antioxidant effect . It show melatonin low multiple sclerosis patient relapse phase comparison disease correlate Multiple Sclerosis Functional Composite score patient . Melatonin also suggest immunomodulatory role . Therefore , hypothesize melatonin effective treatment relapsing-remitting multiple sclerosis patient .</detailed_description>
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis , Relapsing-Remitting</mesh_term>
	<mesh_term>Melatonin</mesh_term>
	<criteria>definite diagnosis relapsingremitting multiple sclerosis EDSS &lt; =5 least 6months consumption interferon beta 1a illiteracy evidence Nystagmus visual acuity lower 5/10 eye relapse last 3 month pregnancy decide become pregnant following year regulatory consumption warfarin , nifedipine , nonsteroidal antiinflammatory drug ( NSAIDs ) , betablockers , fluvoxamine , isoniazide , progestin history epilepsy , stroke , major depression , endocrine , hepatic , hematologic , nephrologic disease</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>